(Q42977642)

12 November 2017

Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient (English)

1 reference

12 November 2017

1 reference

Romain Coriat

1

1 reference

PubMed ID

18397566

12 November 2017

Philippe Podevin

series ordinal

2

1 reference

12 November 2017

1 March 2008

1 reference

International Journal of STD & AIDS

12 November 2017

1 reference

12 November 2017

19

1 reference

12 November 2017

3

1 reference

12 November 2017

208-210

1 reference

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

12 November 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Injection drug users: the overlooked core of the hepatitis C epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Care of patients with hepatitis C and HIV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Potential mechanisms of interferon-alpha induced autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Immune-mediated complications during interferon therapy in hematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007185

21 January 2018

Identifiers

DOI

10.1258/IJSA.2007.007185

1 reference

12 November 2017

1 reference

PubMed ID

18397566